Clinical Trial Update: SCRT Sequential Penpulimab in Combination With CAPEOX in the Neoadjuvant Treatment of MSS Locally Advanced Rectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial is evaluating SCRT sequential Penpulimab with CAPEOX as neoadjuvant therapy for locally advanced rectal cancer and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• OXALIPLATIN (Oxaliplatin)
• Penpulimab

Snippet

Sponsor: Ruijin Hospital | Conditions: Rectal Cancer, Locally Advanced | Phase 2 | Status: RECRUITING